View in EDS

A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023.

Saved in:
Bibliographic Details
Title: A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023.
Authors: Jallorina A; California University of Science and Medicine, Colton, CA., Vij K; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Wan L; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Thomas J; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Drum D; California University of Science and Medicine, Colton, CA., Glick SA; SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY., Lee-Wong MF; Icahn School of Medicine at Mount Sinai, Division of Allergy and Clinical Immunology, Department of Medicine, New York, NY; and.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY.
Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2025 Feb 01; Vol. 85 (2), pp. 97-107. Date of Electronic Publication: 2025 Feb 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39636124
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jallorina+A%22">Jallorina A</searchLink>; California University of Science and Medicine, Colton, CA.<br /><searchLink fieldCode="AU" term="%22Vij+K%22">Vij K</searchLink>; West Virginia School of Osteopathic Medicine, Lewisburg, WV.<br /><searchLink fieldCode="AU" term="%22Wan+L%22">Wan L</searchLink>; West Virginia School of Osteopathic Medicine, Lewisburg, WV.<br /><searchLink fieldCode="AU" term="%22Thomas+J%22">Thomas J</searchLink>; West Virginia School of Osteopathic Medicine, Lewisburg, WV.<br /><searchLink fieldCode="AU" term="%22Drum+D%22">Drum D</searchLink>; California University of Science and Medicine, Colton, CA.<br /><searchLink fieldCode="AU" term="%22Glick+SA%22">Glick SA</searchLink>; SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY.<br /><searchLink fieldCode="AU" term="%22Lee-Wong+MF%22">Lee-Wong MF</searchLink>; Icahn School of Medicine at Mount Sinai, Division of Allergy and Clinical Immunology, Department of Medicine, New York, NY; and.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227902492%22">Journal of cardiovascular pharmacology</searchLink> [J Cardiovasc Pharmacol] 2025 Feb 01; Vol. 85 (2), pp. 97-107. <i>Date of Electronic Publication: </i>2025 Feb 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7902492 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4023 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201602446%22">01602446 </searchLink><i>NLM ISO Abbreviation: </i>J Cardiovasc Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39636124
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/FJC.0000000000001660
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 97
    Titles:
      – TitleFull: A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jallorina A
      – PersonEntity:
          Name:
            NameFull: Vij K
      – PersonEntity:
          Name:
            NameFull: Wan L
      – PersonEntity:
          Name:
            NameFull: Thomas J
      – PersonEntity:
          Name:
            NameFull: Drum D
      – PersonEntity:
          Name:
            NameFull: Glick SA
      – PersonEntity:
          Name:
            NameFull: Lee-Wong MF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1533-4023
          Numbering:
            – Type: volume
              Value: 85
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of cardiovascular pharmacology
              Type: main
ResultId 1